Evidence map›Paper›PMID 26861017›Full record

ArticlemBio2016

Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection.

Paul J Planet, Dane Parker, Taylor S Cohen, Hannah Smith, Justinne D Leon, Chanelle Ryan, Tobin J Hammer, Noah Fierer, Emily I Chen, Alice S Prince

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Dual regulation of antiviral IFN response byJournal of pharmaceutical analysis · 2026
    Article
  4. Article
  5. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Paul J PlanetDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA Sackler Institute for Comparative Genomics, American Museum of Natural History, New York, New York, USA.
Dane ParkerDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
Taylor S CohenDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
Hannah SmithDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
Justinne D Leon
Chanelle RyanDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA.
Tobin J HammerDepartment of Ecology and Evolutionary Biology, University of Colorado, Boulder, Colorado, USA.
Noah FiererDepartment of Ecology and Evolutionary Biology, University of Colorado, Boulder, Colorado, USA Cooperative Institute for Research in Environmental Sciences, University of Colorado, Boulder, Colorado, USA.
Emily I ChenProteomics Shared Resource at the Herbert Irving Comprehensive Cancer Center & Department of Pharmacology, Columbia University Medical Center, New York, New York, USA.
Alice S PrinceDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA asp7@columbia.edu.
Columbia University · USUniversity of Colorado Boulder · USAmerican Museum of Natural History · USColumbia University Irving Medical Center · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
STAPHYLOCOCCUS AUREUS ACTIVATION OF TNF SIGNALING PATHWAYSR01HL079395 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRINCE, ALICE S · 2006 to 2016
$4.3M
Role of Staphylococcus aureus SpA in Microbial Competition and Host ColonizationK08AI101005 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PLANET, PAUL J · 2012 to 2014
$405k
Role of interferons in Staphylococcus aureus upper respiratory tract infectionR56HL125653 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARKER, DANE · 2015 to 2015
$384k
NCI NIH HHS P30 CA013696NCI NIH HHS P30CA013696NCI NIH HHS P30CA013696-39S3NHLBI NIH HHS HL079395NHLBI NIH HHS R01 HL079395NHLBI NIH HHS R01HL079395NHLBI NIH HHS R56 HL125653NHLBI NIH HHS R56HL125653NIAID NIH HHS K08 AI101005NIAID NIH HHS K08AI101005
6 · The paper itself

Abstract

unlabelledMuch of the morbidity and mortality associated with influenza virus respiratory infection is due to bacterial coinfection with pathogens that colonize the upper respiratory tract such as methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae. A major component of the immune response to influenza virus is the production of type I and III interferons. Here we show that the immune response to infection with influenza virus causes an increase and restructuring of the upper respiratory microbiota in wild-type (WT) mice but not in Il28r(-/-) mutant mice lacking the receptor for type III interferon. Mice lacking the IL-28 receptor fail to induce STAT1 phosphorylation and expression of its regulator, SOCS1. Il28r(-/-) mutant mice have increased expression of interleukin-22 (IL-22), as well as Ngal and RegIIIγ, in the nasal cavity, the source of organisms that would be aspirated to cause pneumonia. Proteomic analysis reveals changes in several cytoskeletal proteins that contribute to barrier function in the nasal epithelium that may contribute to the effects of IL-28 signaling on the microbiota. The importance of the effects of IL-28 signaling in the pathogenesis of MRSA pneumonia after influenza virus infection was confirmed by showing that WT mice nasally colonized before or after influenza virus infection had significantly higher levels of infection in the upper airways, as well as significantly greater susceptibility to MRSA pneumonia than Il28r(-/-) mutant mice did. Our results suggest that activation of the type III interferon in response to influenza virus infection has a major effect in expanding the upper airway microbiome and increasing susceptibility to lower respiratory tract infection. IMPORTANCE: S. aureus and influenza virus are important respiratory pathogens, and coinfection with these organisms is associated with significant morbidity and mortality. The ability of influenza virus to increase susceptibility to S. aureus infection is less well understood. We show here that influenza virus leads to a change in the upper airway microbiome in a type III interferon-dependent manner. Mice lacking the type III interferon receptor have altered STAT1 and IL-22 signaling. In coinfection studies, mice without the type III interferon receptor had significantly less nasal S. aureus colonization and subsequent pneumonia than infected WT mice did. This work demonstrates that type III interferons induced by influenza virus contribute to nasal colonization and pneumonia due to S. aureus superinfection.

Indexed as

SuperinfectionAnimalsCytokinesInterferon LambdaInterleukinsMiceMice, KnockoutMicrobiotaNasal CavityOrthomyxoviridae InfectionsPneumonia, StaphylococcalStaphylococcus aureusCytokinesInterferon Lambdainterferon-lambda protein, mouseInterleukins

Identifiers

PMID26861017
PMCPMC4752601
OpenAlexW2261043905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.